GeoPolitics Pulse

The Heartbeat of World events

Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug

by ·

Now, Novo has appealed to the Singaporean court to freeze the assets of KBP’s founder and chairman, Huang Zhenhua, as a wider lawsuit is prepared back …

​Read More

Related posts:

  1. Singapore biotech tycoon Huang Zhenhua’s assets frozen over US$830m suit after …
  2. Who is Singaporean biotech tycoon Huang Zhenhua, whose assets have been frozen over … – CNA
  3. Baxter sells $4.5B kidney care unit to Carlyle Group for $3.8B – Fierce Biotech Google Alert – Global Debt
  4. Novo Nordisk’s Wegovy weight-loss drug approved in China – Reuters
  5. Novo Nordisk sells hit weight-loss drug in China—at fraction of US price – Ars Technica